GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (FRA:UNJ) » Definitions » EV-to-Revenue

United Laboratories International Holdings (FRA:UNJ) EV-to-Revenue : 1.06 (As of May. 15, 2024)


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, United Laboratories International Holdings's enterprise value is €1,866 Mil. United Laboratories International Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €1,768 Mil. Therefore, United Laboratories International Holdings's EV-to-Revenue for today is 1.06.

The historical rank and industry rank for United Laboratories International Holdings's EV-to-Revenue or its related term are showing as below:

FRA:UNJ' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.35   Med: 1.42   Max: 2.29
Current: 1.05

During the past 13 years, the highest EV-to-Revenue of United Laboratories International Holdings was 2.29. The lowest was 0.35. And the median was 1.42.

FRA:UNJ's EV-to-Revenue is ranked better than
78.36% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs FRA:UNJ: 1.05

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), United Laboratories International Holdings's stock price is €1.12. United Laboratories International Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.97. Therefore, United Laboratories International Holdings's PS Ratio for today is 1.15.


United Laboratories International Holdings EV-to-Revenue Historical Data

The historical data trend for United Laboratories International Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings EV-to-Revenue Chart

United Laboratories International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 0.89 0.52 0.50 0.65

United Laboratories International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 - 0.50 - 0.65

Competitive Comparison of United Laboratories International Holdings's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's EV-to-Revenue falls into.



United Laboratories International Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

United Laboratories International Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1866.289/1767.743
=1.06

United Laboratories International Holdings's current Enterprise Value is €1,866 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. United Laboratories International Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €1,768 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Laboratories International Holdings  (FRA:UNJ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

United Laboratories International Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.12/0.973
=1.15

United Laboratories International Holdings's share price for today is €1.12.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.97.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Laboratories International Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (FRA:UNJ) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (FRA:UNJ) Headlines

No Headlines